Physician

Hematology

Scott B. Saxman practices Hematology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He has 1 awards "Fellow (FACP)". Scott Saxman is also a published doctor. He has 41 publication published. The most recent publication is: A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Publications

---

• Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab foll...
• Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
• Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II tr...
• Proposal for the use of progression-free survival in unblinded randomized trials.
• Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
• Doctor ... will I still be able to have children?
• National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation.
• Clinical trials referral resource. Current clinical trials in mesothelioma.
• Population variations in the initial treatment of non-small-cell lung cancer.
• Molecular targets for radiation therapy: bringing preclinical data into clinical trials.
• Soft tissue sarcomas of adults: state of the translational science.
• Clinical trials referral resource. Current clinical trials of imatinib mesylate.
• Clinical trails referral resource. Clinical trials in soft tissue sarcomas.
• Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.
• Clinical trials referral resource. Current clinical trials in small-cell lung cancer.
• Oral etoposide in germ cell tumours.
• Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
• Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
• Clinical trials referral resource. Current trials in melanoma.
• Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
• A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
• Primary salvage treatment of recurrent germ cell tumors: experience at Indiana University.
• Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
• Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
• Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian Univers...
• Breast cancer associated with palmar fasciitis and arthritis.
• Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic ur...
• Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
• Mantle cell lymphoma appearing as a tongue base mass.
• The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
• Images in clinical medicine. Acid-fast organisms.
• Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience.
• Red cell fragmentation produced by renal artery stenosis.
• Mediastinal yolk sac tumor. The Indiana University experience, 1976 to 1988.
• Cloning and characterization of the murine promoter for the colony-stimulating factor-1-encoding gene.
• Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience.
• Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.
• Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study.
• Salvage therapy in recurrent testicular cancer.
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Schools

---

• Indiana University School of Medicine

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Fellow (FACP)

Education

---

• Indiana University School of Medicine
• Vanderbilt University

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Anna Maria V. Storniolo, MD This Doctor is OpenDoctor Recommended.
	Dr. Radhika V. Walling, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert D. Vallion, MD
	Dr. David P. Gray, MD
	Dr. Datchen F. Tai, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeremy M. Force, MD
	Dr. Larry D. Cripe, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Michael J. Robertson, MD This Doctor is OpenDoctor Recommended.
	Dr. Devena E. Alston-Johnson, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer E. Schwartz, MD This Doctor is OpenDoctor Recommended.
	Dr. Mary L. Mayer, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher A. Slapak, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul R. Helft, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Amy E. Schmidt, MD
	Dr. Praveen Ranganath, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog